-
October 28, 2026
A man told a New Jersey federal court that he was forced to pay excessive and avoidable fees to an attorney hired to represent him in a property damage dispute after the attorney mishandled the case by failing to advise him to tender the claim to his homeowners insurer.
-
October 28, 2026
The head of the U.S. Patent and Trademark Office has turned down Pogona LLC's argument that Merck's challenge to a patent on selecting a type of bacteria to use in a vaccine against pneumococcal disease was an "abusive" attack on the patent.
-
October 28, 2026
An electronics maker alleged in New Jersey federal court that the wireless charging feature in certain BMW models directly infringes its patent for a method of transferring power to a mobile device.
-
October 28, 2026
A New Jersey municipal judge was admonished Wednesday by the state supreme court following after he admitted his decision to wear pro-Palestine clothing to a judicial training conference fell short of the standards and expectations of his position.
-
October 28, 2026
Retirement plan participants and beneficiaries told a New Jersey federal court in a proposed Employee Retirement Income Security Act class action that a hospital network mismanaged their "jumbo-sized" plan.
-
October 27, 2026
FCA US LLC has agreed to pay up to $5 million to resolve proposed class claims alleging it sold Jeep Wrangler plug-in hybrid vehicles with a defect that renders electric driving unavailable, while class counsel plans to seek an additional $2 million in fees, costs, expenses and incentive awards.
-
October 27, 2026
A New Jersey federal judge has upheld the U.S. Patent and Trademark Office's refusal to extend the life of a pair of patents on a cancer drug, rejecting a challenge from the patent owner that claimed the loss of exclusivity would cost it more than $1 billion.
-
October 27, 2026
The New Jersey Department of Environmental Protection backed various DuPont entities' bid to toss the remaining claims in a municipality's $1 billion lawsuit over forever chemical contamination stemming from a longtime DuPont facility, arguing that a landmark settlement the state reached earlier this year bars the claims.
-
October 27, 2026
An investor is suing UP Fintech Holding Ltd. in New Jersey federal court, alleging the fintech company and its top brass misrepresented and understated its legal and regulatory risk "as a result of continued illegal activity in China."
-
October 27, 2026
Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.
-
October 27, 2026
An ex-worker hit M&T Bank with a proposed class action in New Jersey federal court, alleging that an underperforming investment fund in the bank's employee 401(k) plan cost workers tens of millions in future savings, breaching fiduciary duties under federal benefits law.
-
October 27, 2026
A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.
-
October 27, 2026
The New Jersey Administrative Office of the Courts urged a state court to toss a former municipal judge's retaliation claims, arguing that the office is not the judge's employer and that his suit lacks facts to support the claims.
-
October 27, 2026
Nearly two dozen states sued the Trump administration Tuesday over its rollback of ownership reporting requirements for corporate entities, arguing the move constitutes an illegal, unilateral repeal of an anti-financial crime law that Congress enacted.
-
October 26, 2026
A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "false superiority messages," ruling that Novo Nordisk hasn't shown it would be irreparably harmed.
-
October 26, 2026
The Trump administration is again asking a California federal judge to toss a coalition of states' lawsuit challenging its decision to cut vaccine recommendations for children, arguing that the states cannot show harm that gives them standing to sue.
-
October 26, 2026
The Federal Trade Commission and a group of 20 states announced a lawsuit in Tennessee federal court, alleging Monday that Dollar General Corp. holds itself out as an accessible retailer for low- and fixed-income consumers, but has for years charged shoppers more at the register than the displayed prices.
-
October 26, 2026
Fragrance ingredient buyers and the attorneys who helped them secure $59 million in price-fixing settlements are now asking a New Jersey federal court for final approval and the green light to set aside a third of those funds for legal counsel.
-
October 26, 2026
The World Series matchup between Foley & Lardner LLP clients, the Milwaukee Brewers and the Tampa Bay Rays, has pitted partners against one another as the firm enjoys a good-natured intrasquad rivalry during the Fall Classic.
-
October 26, 2026
A New Jersey bankruptcy judge Monday signed off on a $13 million settlement between unsecured creditors of former summer camp operator SIMAD Holdings and its biggest secured lender, despite the IRS' objection to the deal.
-
October 26, 2026
Obesity-focused biopharmaceutical company Corxel Pharmaceuticals Inc. on Monday unveiled plans to go public by merging with special-purpose acquisition company Amanat Acquisition Corp. in a deal expected to generate roughly $377 million in gross proceeds and that was built by three law firms.
-
October 26, 2026
A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.
-
October 26, 2026
Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the Third Circuit after a New Jersey federal judge refused to toss it.
-
October 26, 2026
A Pennsylvania lawyer told the Third Circuit on Monday that she deserves a new trial in her suit against three Blank Rome LLP lawyers and an aircraft parts company, arguing that the trial court did not properly view all the evidence.
-
October 23, 2026
Catch up on this past week's key developments by state from Law360 Real Estate Authority — including a look at states with data center bans on the ballot and one practice group leader's perspective on multifamily concerns ahead.